Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

NCT00321763 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3124

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Candidate Influenza Vaccine GSK1247446A - 3 different formulations
BIOLOGICAL: Fluarix TM

Sponsor

GlaxoSmithKline